Cargando…
Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma
BACKGROUND: We previously reported that expressions of the pro-angiogenic cytokines angiopoietin-2 (Ang-2), follistatin, granulocyte colony-stimulating factor, hepatocyte growth factor, leptin, platelet-derived growth factor-BB, platelet endothelial cell adhesion molecule-1, and vascular endothelial...
Autores principales: | Miyahara, K, Nouso, K, Morimoto, Y, Takeuchi, Y, Hagihara, H, Kuwaki, K, Onishi, H, Ikeda, F, Miyake, Y, Nakamura, S, Shiraha, H, Takaki, A, Honda, M, Kaneko, S, Sato, T, Sato, S, Obi, S, Iwadou, S, Kobayashi, Y, Takaguchi, K, Kariyama, K, Takuma, Y, Takabatake, H, Yamamoto, K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798958/ https://www.ncbi.nlm.nih.gov/pubmed/24045661 http://dx.doi.org/10.1038/bjc.2013.554 |
Ejemplares similares
-
Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma
por: Toshikuni, N, et al.
Publicado: (2000) -
Droplet digital PCR measurement of HER2 in patients with gastric cancer
por: Kinugasa, H, et al.
Publicado: (2015) -
Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis
por: Nouso, K, et al.
Publicado: (2008) -
The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab
por: Takeuchi, Yasuto, et al.
Publicado: (2023) -
Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
por: Ikeda, M., et al.
Publicado: (2016)